Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Alan Meds vs NuBloom

Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, NuBloom a 72. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Alan Meds

#7 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Alan Meds review →
VS

NuBloom

#201 · Grade C · Watch List

Est. first month

From $149/mo (compounded)

Save ~89% vs brand-name
Get this deal Full NuBloom review →

The verdict

Better value: Alan Meds

Alan Meds takes it on Value Score, 90 to 72 an est. $99/mo first month, with no teaser step-up baked in. NuBloom isn't out of it: Shoppers who want women seeking a physician-founded, whole-person GLP-1 and hormone program with optional 1:1 coaching.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealAlan MedsNuBloom
Value Score90 (A)72 (C)
Est. first month$99/moFrom $149/mo (compounded)
Save vs brand-name~93%~89%
Semaglutide$99/moFrom $149/mo (compounded)
Tirzepatide$145/moFrom $249/mo (compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 states49 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
82
Alan Meds: 95. NuBloom: 82.
85
No Teaser-Rate Bait
38
Alan Meds: 85. NuBloom: 38.
98
Nationwide Availability
88
Alan Meds: 98. NuBloom: 88.
94
Both Molecules
92
Alan Meds: 94. NuBloom: 92.
82
Easy Cancellation
58
Alan Meds: 82. NuBloom: 58.
72
Reputation
77
Alan Meds: 72. NuBloom: 77.

Alan Meds

Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.

Why it's a deal

  • $99 flat semaglutide and a low $145 tirzepatide
  • Available in all 50 states
  • Offers an oral/sublingual route

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Newer operator with a thin public track record

NuBloom

NuBloom is a women's metabolic-health telehealth practice founded by family and integrative-medicine physician Dr.

Why it's a deal

  • Transparent, openly published pricing: compounded semaglutide $149/mo and tirzepatide $279/mo as flexible month-to-month subscriptions
  • Founded and medically led by a named physician (Dr. Marianne Pinkston Mueller, family/integrative medicine, 25+ years)
  • Whole-person model pairs GLP-1s with hormone, gut-health and longevity care plus in-depth lab testing
  • State coverage published openly: 49 states listed on the site (all except Mississippi)
  • Optional 90-day 1:1 coaching program with weekly meetings and unlimited text support ($599/mo)

The fine print

  • Compounding pharmacy partners are not named anywhere on the site — a transparency gap
  • NuBloom's own LegitScript/PCAB status is not displayed; only its telehealth partner is certified
  • Compounded medications are not FDA-approved; one FAQ loosely calls them 'FDA-approved,' contradicting the product pages
  • All sales are final and medical consult fees are non-refundable; no returns on prescription products
  • Disputes go to binding individual arbitration; the Terms' governing-law state is left as an unfilled '[STATE]' placeholder
Get the Alan Meds deal Get the NuBloom deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to NuBloom.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.